World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
78
Citations
19663
World Ranking
1774
National Ranking
875

Carl R. Alving publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Carl R. Alving sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 336 publications — 71st percentile

71% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Carl R. Alving D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Carl R. Alving sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 78 D-Index — 65th percentile

65% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2016 - Fellow, National Academy of Inventors
  • 1988 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Carl R. Alving is affiliated with the Walter Reed Army Institute of Research in the United States. The core focus of their research lies in immunology, molecular biology, and medicine, with specific attention to immunotherapy and immune responses. Their work spans several related fields, including epidemiology, virology, infectious diseases, biochemistry, genetics, and molecular biology.

Their scientific contributions include published research in multiple well-known venues. Frequent publication sites include:

  • Vaccines
  • Pharmaceutics
  • Open Forum Infectious Diseases
  • Expert Review of Vaccines
  • PLoS Pathogens

Among recent papers authored or co-authored by Carl R. Alving are:

  • "Army Liposome Formulation (ALF) family of vaccine adjuvants," 2020, Expert Review of Vaccines
  • "Adjuvanted HIV-1 vaccine promotes antibody-dependent phagocytic responses and protects against heterologous SHIV challenge," 2020, PLoS Pathogens
  • "Malaria transmission-blocking conjugate vaccine in ALFQ adjuvant induces durable functional immune responses in rhesus macaques," 2021, npj Vaccines
  • "Design of Alphavirus Virus-Like Particles Presenting Circumsporozoite Junctional Epitopes That Elicit Protection against Malaria," 2021, Vaccines
  • "Similarities and differences of chemical compositions and physical and functional properties of adjuvant system 01 and army liposome formulation with QS21," 2023, Frontiers in Immunology

Their research topics cover several areas including:

  • Immunotherapy and Immune Responses
  • Influenza Virus Research Studies
  • HIV Research and Treatment
  • RNA Interference and Gene Delivery
  • Vaccines and Immunoinformatics Approaches
  • Viral Gastroenteritis Research and Epidemiology
  • Malaria Research and Control

Carl R. Alving often collaborates with a range of co-authors. Some frequent collaborators include:

  • Gary R. Matyas
  • Mangala Rao
  • Zoltán Beck
  • Kristina K. Peachman
  • Clara J. Sei

The scientist has been recognized by professional organizations with awards such as:

  • Fellow, National Academy of Inventors, 2016
  • Fellow of the American Association for the Advancement of Science (AAAS), 1988

Best Publications

  • Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil®): possible role in hypersensitivity reactions

    Asher Chanan-Khan;J. Szebeni;S. Savay;L. Liebes

  • Liposomes as carriers of antigens and adjuvants.

    Carl R. Alving

  • Transcutaneous immunization: a human vaccine delivery strategy using a patch.

    Gregory M. Glenn;David N. Taylor;Xiuru Li;Sarah Frankel

  • Skin immunization made possible by cholera toxin

    Gregory M. Glenn;Mangala Rao;Gary R. Matyas;Carl R. Alving

  • Complement Activation by Cremophor EL as a Possible Contributor to Hypersensitivity to Paclitaxel: an In Vitro Study

    Janos Szebeni;Franco M. Muggia;Franco M. Muggia;Carl R. Alving

  • Therapy of leishmaniasis: Superior efficacies of liposome-encapsulated drugs

    Carl R. Alving;Edgar A. Steck;Willie L. Chapman;Virginia B. Waits

  • Liposome carriers in chemotherapy of leishmaniasis

    Edgar A. Steck;Carl R. Alving

  • Liposomal malaria vaccine in humans: a safe and potent adjuvant strategy

    Louis F. Fries;Daniel M. Gordon;Roberta L. Richards;James E. Egan

  • Adjuvants for human vaccines

    Carl R Alving;Kristina K Peachman;Mangala Rao;Steven G Reed

  • F(ab)'2-mediated neutralization of C3a and C5a anaphylatoxins: a novel effector function of immunoglobulins.

    Milan Basta;Fredric Van Goor;Stefano Luccioli;Eric M. Billings

  • Complement-dependent damage to liposomes prepared from pure lipids and Forssman hapten.

    Stephen C. Kinsky;James A. Haxby;David A. Zopf;Carl R. Alving

  • Role of complement activation in hypersensitivity reactions to doxil and hynic PEG liposomes: experimental and clinical studies.

    J. Szebeni;L. Baranyi;S. Savay;J. Milosevits

  • Lipopolysaccharide, lipid A, and liposomes containing lipid A as immunologic adjuvants

    Carl R. Alving

  • Hemodynamic Changes Induced by Liposomes and Liposome-Encapsulated Hemoglobin in Pigs A Model for Pseudoallergic Cardiopulmonary Reactions to Liposomes: Role of Complement and Inhibition by Soluble CR1 and Anti-C5a Antibody

    Janos Szebeni;John L. Fontana;Nabila M. Wassef;Paul D. Mongan

  • Transcutaneous Immunization with Bacterial ADP-Ribosylating Exotoxins, Subunits, and Unrelated Adjuvants

    Tanya Scharton-Kersten;Jian-mei Yu;Russell Vassell;Derek O'Hagan

  • Transcutaneous immunization with cholera toxin protects mice against lethal mucosal toxin challenge.

    Gregory M. Glenn;Tanya Scharton-Kersten;Russell Vassell;Corey P. Mallett

  • Animal Models of Complement-Mediated Hypersensitivity Reactions to Liposomes and Other Lipid-Based Nanoparticles

    János Szebeni;Carl R. Alving;László Rosivall;Rolf Bünger

  • Safety and Immunogenicity of a Prototype Enterotoxigenic Escherichia coli Vaccine Administered Transcutaneously

    Fernando Güereña-Burgueño;Eric R. Hall;David N. Taylor;Frederick J. Cassels

  • Liposome-induced pulmonary hypertension: properties and mechanism of a complement-mediated pseudoallergic reaction

    Janos Szebeni;Lajos Baranyi;Sandor Savay;Mihaly Bodo

  • Transcutaneous immunization with bacterial ADP-ribosylating exotoxins as antigens and adjuvants.

    Gregory M. Glenn;Tanya Scharton-Kersten;Russell Vassell;Gary R. Matyas

  • Liposomes as carriers of peptide antigens: induction of antibodies and cytotoxic T lymphocytes to conjugated and unconjugated peptides.

    C. R. Alving;V. Koulchin;G. M. Glenn;Mangala Rao

Frequent Co-Authors

Janos Szebeni
Janos Szebeni Semmelweis University
Andrew S. Janoff
Andrew S. Janoff Princeton University
Kenner C. Rice
Kenner C. Rice National Institutes of Health
Arthur E. Jacobson
Arthur E. Jacobson National Institutes of Health
Victoria R. Polonis
Victoria R. Polonis Walter Reed Army Institute of Research
Nelson L. Michael
Nelson L. Michael Walter Reed Army Institute of Research
Venigalla B. Rao
Venigalla B. Rao Catholic University of America
Jerome H. Kim
Jerome H. Kim Walter Reed Army Institute of Research
Joel Moss
Joel Moss National Institutes of Health
Stephen H. Leppla
Stephen H. Leppla National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring online nursing degrees can be a valuable pathway into healthcare roles that intersect with immunological expertise. Programs like pmhnp programs online with best clinical placement offer specialized training in psychiatric mental health, a field where understanding the immune system’s impact on mental health is increasingly important.

Cost is a significant factor for many prospective students. Fortunately, there are cheap psych np programs that provide quality education without the heavy financial burden, making advanced nursing education more accessible for those aiming to combine nursing with immunology-related disciplines.

Graduates pursuing a Doctor of Nursing Practice (DNP) can expect competitive salaries that vary by location. Understanding the dnp salary differences can help future students make informed decisions about where to study and work after graduation.

For family nurse practitioners looking to specialize further, pursuing acute care certification for fnp is an excellent way to transition into roles that often work closely with immunology-related critical care, expanding career opportunities in hospital settings and beyond.

Best Scientists Citing Carl R. Alving

Trending Scientists

Recently Published Articles